Hypokalemic periodic paralysis: genes and variants
Explore variant evidence for Hypokalemic periodic paralysis across 3 analyzed proteins (CACNA1S, SCN4A, CLCN1). Linked ClinVar records include 26 pathogenic or likely pathogenic variants, 696 variants of uncertain significance and 288 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Hypokalemic periodic paralysis
CACNA1S: Voltage-dependent L-type calcium channel subunit alpha-1S
Its voltage sensing in skeletal-muscle transverse tubules mechanically activates RYR1 and couples membrane depolarization to sarcoplasmic-reticulum calcium release. Pathogenic variants can cause hypokalemic periodic paralysis, malignant-hyperthermia susceptibility, and congenital myopathy.
14 ClinVar pathogenic / likely pathogenic and 850 uncertain variants in CACNA1S have source records linked to Hypokalemic periodic paralysis. Association strength is not clinical gene validity.
SCN4A: Sodium channel protein type 4 subunit alpha
Its rapid sodium current initiates and propagates skeletal-muscle action potentials. Gain- and loss-of-function variants cause disorders of muscle excitability including sodium-channel myotonia, paramyotonia congenita, periodic paralysis, and some congenital myopathies.
11 ClinVar pathogenic / likely pathogenic and 134 uncertain variants in SCN4A have source records linked to Hypokalemic periodic paralysis. Association strength is not clinical gene validity.
CLCN1: Chloride channel protein 1
Its chloride conductance stabilizes the resting membrane potential of skeletal muscle and prevents repetitive firing after contraction. Loss-of-function variants cause myotonia congenita, with delayed muscle relaxation and stiffness.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CLCN1 have source records linked to Hypokalemic periodic paralysis. Association strength is not clinical gene validity.
Where Hypokalemic periodic paralysis variants cluster
- SCN4A S4 of repeat II (positions 665–682): 4 of 11 ClinVar pathogenic / likely pathogenic variants, 37.1× more than its size predicts (a length-based count, not a validated hotspot).
- CACNA1S S4 of repeat III (positions 893–911): 4 of 14 ClinVar pathogenic / likely pathogenic variants, 28.2× more than its size predicts (a length-based count, not a validated hotspot).
- SCN4A S4 of repeat IV (positions 1446–1462): 3 of 11 ClinVar pathogenic / likely pathogenic variants, 29.4× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Hypokalemic periodic paralysis
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CACNA1S R1239G | 1239 | IV | Pathogenic / likely pathogenic (★★) |
| SCN4A R672H | 672 | II | Pathogenic / likely pathogenic (★★) |
| SCN4A R1135H | 1135 | III | Pathogenic / likely pathogenic (★★) |
| CACNA1S R528C | 528 | II | Pathogenic / likely pathogenic (★★) |
| CACNA1S R897T | 897 | III | Pathogenic / likely pathogenic (★★) |
| SCN4A R672C | 672 | II | Pathogenic / likely pathogenic (★★) |
| SCN4A R1135S | 1135 | III | Pathogenic / likely pathogenic (★★) |
| SCN4A R222W | 222 | I | Pathogenic / likely pathogenic (★★) |
| SCN4A R669H | 669 | II | Pathogenic / likely pathogenic (★★) |
| SCN4A R1448C | 1448 | IV | Pathogenic / likely pathogenic (★★) |
| SCN4A R1460Q | 1460 | IV | Pathogenic / likely pathogenic (★★) |
| CACNA1S R1086S | 1086 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| CACNA1S R1239H | 1239 | IV | Pathogenic / likely pathogenic (★★) |
| SCN4A R675Q | 675 | II | Pathogenic / likely pathogenic (★★) |
| SCN4A M1592V | 1592 | IV | Pathogenic / likely pathogenic (★★) |
| CACNA1S R897K | 897 | III | Pathogenic / likely pathogenic (★) |
| CACNA1S R900M | 900 | III | Pathogenic / likely pathogenic (★) |
| CACNA1S R900S | 900 | III | Pathogenic / likely pathogenic (★) |
| CACNA1S M578I | 578 | II | Pathogenic / likely pathogenic (★) |
| CACNA1S A1092V | 1092 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| CACNA1S V130D | 130 | I | Pathogenic / likely pathogenic (★) |
| CACNA1S F569L | 569 | II | Pathogenic / likely pathogenic (★) |
| CACNA1S V876E | 876 | III | Pathogenic / likely pathogenic (★) |
| SCN4A G1456W | 1456 | IV | Pathogenic / likely pathogenic (★) |
| CACNA1S R528G | 528 | II | Pathogenic / likely pathogenic |
| CLCN1 R672G | 672 | Cytoplasmic | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Hypokalemic periodic paralysis
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| CACNA1S R1239C | 1239 | IV | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; R1239H at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.964 |
| CACNA1S R897S | 897 | III | Conflicting reports (★) | +7: 4 other pathogenic changes within 3 positions; R897T at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.896 |
| CACNA1S R1086G | 1086 | Cytoplasmic | Uncertain (★★) | +7: R1086S at the same position is pathogenic; seen in 2e-06 of gnomAD DNA copies; REVEL 0.947 |
| CACNA1S M578V | 578 | II | Uncertain (★) | +7: in a 3D region that tolerates change poorly (3R); M578I at the same position is pathogenic; seen in 1.4e-06 of gnomAD DNA copies; REVEL 0.918 |
| CACNA1S R1086C | 1086 | Cytoplasmic | Conflicting reports (★) | +6: R1086S at the same position is pathogenic; REVEL 0.956 |
| CACNA1S R897G | 897 | III | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; R897T at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.89 |
| CACNA1S R528L | 528 | II | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; R528G at the same position is pathogenic; REVEL 0.976 |
| CACNA1S R900G | 900 | III | Uncertain (★) | +6: 4 other pathogenic changes within 3 positions; R900M at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.95 |
Which prediction tools work for Hypokalemic periodic paralysis
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 97 out of 100
- MutPred: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 96 out of 100
- EVE: 96 out of 100
- MetaLR: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 87 out of 100
- SIFT: 86 out of 100
- phyloP: 80 out of 100
- PolyPhen-2: 77 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 52 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 42 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Hyperkalemic periodic paralysis also has ClinVar records linked to SCN4A variants; they fall mostly in different places as the Hypokalemic periodic paralysis variants (62 pathogenic / likely pathogenic).
- Paramyotonia congenita of Von Eulenburg also has ClinVar records linked to SCN4A variants; they fall mostly in different places as the Hypokalemic periodic paralysis variants (15 pathogenic / likely pathogenic).
- Potassium-aggravated myotonia also has ClinVar records linked to SCN4A variants; they fall partly in the same places as the Hypokalemic periodic paralysis variants (14 pathogenic / likely pathogenic).
- Congenital myopathy 22A, classic also has ClinVar records linked to SCN4A variants; they fall partly in the same places as the Hypokalemic periodic paralysis variants (8 pathogenic / likely pathogenic).
- Myasthenic syndrome also has ClinVar records linked to SCN4A variants; they fall mostly in different places as the Hypokalemic periodic paralysis variants (7 pathogenic / likely pathogenic).
- Myotonia, autosomal dominant form also has ClinVar records linked to CLCN1 variants; they fall mostly in different places as the Hypokalemic periodic paralysis variants (92 pathogenic / likely pathogenic).
- Congenital myotonia, autosomal recessive form also has ClinVar records linked to CLCN1 variants; they fall mostly in different places as the Hypokalemic periodic paralysis variants (90 pathogenic / likely pathogenic).
- Skeletal muscle channelopathy also has ClinVar records linked to CLCN1 variants; they fall mostly in different places as the Hypokalemic periodic paralysis variants (11 pathogenic / likely pathogenic).
Diseases related to Hypokalemic periodic paralysis
- Skeletal muscle channelopathy, also linked to CACNA1S, CLCN1 and SCN4A
- Hyperkalemic periodic paralysis, also linked to CLCN1 and SCN4A
- Epilepsy, also linked to CACNA1S and SCN4A
- Migraine, also linked to CLCN1 and SCN4A
- Amyotrophic lateral sclerosis, also linked to SCN4A
- Myotonia, autosomal dominant form, also linked to CLCN1
- Congenital myotonia, autosomal recessive form, also linked to CLCN1
- Cardiac arrhythmia, also linked to SCN4A
- Sotos syndrome, also linked to SCN4A
- Diabetes mellitus, also linked to CACNA1S
- Myasthenic syndrome, also linked to SCN4A
- Paramyotonia congenita of Von Eulenburg, also linked to SCN4A
Frequently asked questions
Which genes have records linked to Hypokalemic periodic paralysis?
This view contains 3 analyzed proteins: CACNA1S, SCN4A, CLCN1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 26 pathogenic or likely pathogenic variants, 696 variants of uncertain significance and 288 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 8 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 1,083 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center